CVI Investments, Inc. 13D and 13G filings for Can-Fite BioPharma Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:23 pm Unchanged |
2021-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
CVI Investments, Inc. | 231,616,500 3.700% |
0 (Unchanged) |
Filing |
| 2021-02-16 09:54 am Sale |
2020-12-31 | 13G | Can-Fite BioPharma Ltd. CANF |
CVI Investments, Inc. | 231,616,500 5.000% |
-61,066,500 (-20.86%) |
Filing |
| 2020-06-19 06:02 am Purchase |
2020-06-10 | 13G | Can-Fite BioPharma Ltd. CANF |
CVI Investments, Inc. | 292,683,000 7.100% |
292,683,000 (New Position) |
Filing |